Avidity Biosciences Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 12,475 | 3,847 | 1,573 | 2,973 | 2,336 |
| Gross Profit | 12,475 | 3,847 | 1,573 | 2,973 | 2,336 |
| Operating Expenses | 201,281 | 174,989 | 133,090 | 123,962 | 100,470 |
| Operating Income | -188,806 | -171,142 | -131,517 | -120,989 | -98,134 |
| Other Income | 14,364 | 13,827 | 15,744 | 18,733 | 17,736 |
| Pre-tax Income | -174,442 | -157,315 | -115,773 | -102,256 | -80,398 |
| Net Income Continuous | -174,442 | -157,315 | -115,773 | -102,256 | -80,398 |
| Net Income | $-174,442 | $-157,315 | $-115,773 | $-102,256 | $-80,398 |
| EPS Basic Total Ops | -1.27 | -1.21 | -0.90 | -0.80 | -0.65 |
| EPS Basic Continuous Ops | -1.27 | -1.21 | -0.90 | -0.79 | -0.65 |
| EPS Diluted Total Ops | -1.27 | -1.21 | -0.90 | -0.80 | -0.65 |
| EPS Diluted Continuous Ops | -1.27 | -1.21 | -0.90 | -0.79 | -0.65 |
| EPS Diluted Before Non-Recurring Items | -1.27 | -1.21 | -0.90 | -0.80 | -0.65 |
| EBITDA(a) | $-190,155 | $-173,803 | $-135,889 | $-127,417 | $-104,270 |